PCN31 Economic Evaluation of Azacitidine for the Treatment of Myelodysplastic Syndromes (MDS) in the Brazilian Public Health Care System (SUS)

Autor:	O.A.C. Clark, Zeba M. Khan, C. Pepe, L. Paladini, T. Tencer
Rok vydání:	2012
Předmět:	medicine.medical_specialty business.industry Health Policy Myelodysplastic syndromes Economic evaluation Azacitidine Public Health Environmental and Occupational Health medicine Intensive care medicine medicine.disease business Public health care medicine.drug
Zdroj:	Value in Health. 15:A212-A213
ISSN:	1098-3015
DOI:	10.1016/j.jval.2012.03.1148
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbe67469949355be4f5600da98fec6cb https://doi.org/10.1016/j.jval.2012.03.1148 Zobrazit plný text záznamu Full Text from ScienceDirect